John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$166M |
| 2 |
General Motors
GM
|
+$156M |
| 3 |
Union Pacific
UNP
|
+$154M |
| 4 |
Pfizer
PFE
|
+$124M |
| 5 |
McDonald's
MCD
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$132M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$124M |
| 3 |
Liberty Global Class A
LBTYA
|
+$120M |
| 4 |
Freeport-McMoran
FCX
|
+$110M |
| 5 |
Vodafone
VOD
|
+$80.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.69% |
| 2 | Healthcare | 12.24% |
| 3 | Technology | 11.21% |
| 4 | Energy | 10.78% |
| 5 | Financials | 10.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Cytokinetics
CYTK
$10.7B
| $278K | ﹤0.01% |
+36,726
| New | +$394K |
|
|
AFAM
1527
DELISTED
Almost Family Inc
AFAM
| $277K | ﹤0.01% |
14,238
-14,506
| -50% | -$279K |
|
1528
Univest Financial
UVSP
$1.15B
| $275K | ﹤0.01% |
+14,557
| New | +$288K |
|
1529
Preferred Bank
PFBC
$1.23B
| $274K | ﹤0.01% |
15,371
+1,572
| +11% | +$26.6K |
|
|
AMAG
1530
DELISTED
AMAG Pharmaceuticals
AMAG
| $274K | ﹤0.01% |
12,751
-54,235
| -81% | -$1.28M |
|
|
IVAC
1531
DELISTED
Intevac Inc
IVAC
| $273K | ﹤0.01% |
46,546
+21,845
| +88% | +$135K |
|
|
NOR
1532
DELISTED
NORANDA ALUM HLDG CORP COM NEW
NOR
| $273K | ﹤0.01% |
15,825
+9,752
| +161% | +$205K |
|
|
MESG
1533
DELISTED
XURA INC COM (DE)
MESG
| $272K | ﹤0.01% |
+8,498
| New | +$265K |
|
1534
Stock Yards Bancorp
SYBT
$2.54B
| $271K | ﹤0.01% |
14,331
-21,419
| -60% | -$387K |
|
1535
Humana
HUM
$46.4B
| $270K | ﹤0.01% |
2,893
-128,736
| -98% | -$11.8M |
|
1536
iShares US Home Construction ETF
ITB
$2.28B
| $269K | ﹤0.01% |
+12,053
| New | +$265K |
|
|
PRGX
1537
DELISTED
PRGX Global, Inc.
PRGX
| $269K | ﹤0.01% |
42,911
-3,674
| -8% | -$22.3K |
|
|
HOME
1538
DELISTED
HOME FED BANCORP INC COM STK NEW (MD)
HOME
| $268K | ﹤0.01% |
21,338
+9,244
| +76% | +$125K |
|
|
XOXO
1539
DELISTED
Xo Group Inc
XOXO
| $267K | ﹤0.01% |
20,659
-25,061
| -55% | -$314K |
|
1540
Nexstar Media Group
NXST
$5.74B
| $266K | ﹤0.01% |
+5,966
| New | +$213K |
|
1541
WPP
WPP
$5.83B
| $266K | ﹤0.01% |
+2,580
| New | +$243K |
|
|
TIVO
1542
DELISTED
Tivo Inc
TIVO
| $266K | ﹤0.01% |
13,857
-393,420
| -97% | -$7.86M |
|
|
FRM
1543
DELISTED
FURMANITE CORPORATION COM
FRM
| $266K | ﹤0.01% |
26,900
-16,904
| -39% | -$146K |
|
1544
Artivion
AORT
$1.31B
| $265K | ﹤0.01% |
37,875
-9,732
| -20% | -$65.9K |
|
1545
Universal Technical Institute
UTI
$1.21B
| $263K | ﹤0.01% |
+21,655
| New | +$247K |
|
|
APEX
1546
DELISTED
Apex Global Brands Inc. Common Stock
APEX
| $263K | ﹤0.01% |
674
+112
| +20% | +$42.2K |
|
|
ABMD
1547
DELISTED
Abiomed Inc
ABMD
| $262K | ﹤0.01% |
13,746
-115,706
| -89% | -$2.65M |
|
|
NWY
1548
DELISTED
New York & Co Inc
NWY
| $262K | ﹤0.01% |
45,284
+44
| +0.1% | +$257 |
|
|
CDI
1549
DELISTED
CDI Corp.
CDI
| $262K | ﹤0.01% |
17,143
-9,288
| -35% | -$138K |
|
1550
MaxLinear
MXL
$5.69B
| $261K | ﹤0.01% |
+31,484
| New | +$245K |
|
Similar funds
John Overdeck's Q3 2013 Portfolio in Review
As of Q3 2013, John Overdeck held 2,423 positions worth $15.7B, up 9.6% from $14.3B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
John Overdeck deployed $511M of net new capital in Q3 2013, opening 482 new positions and adding to 549 existing holdings. Its largest new stake was Johnson & Johnson: 1,855,436 shares worth $161M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was EMC CORPORATION, an estimated $124M trimmed.
- John Overdeck's largest Q3 2013 buy was Johnson & Johnson: 1,855,436 shares worth $161M.
- John Overdeck added most to Alphabet (Google) Class C in Q3 2013, an estimated $100M increase.
- John Overdeck's biggest Q3 2013 reduction was EMC CORPORATION, cutting an estimated $124M.
- John Overdeck fully exited IBM in Q3 2013, selling an estimated $132M.
- John Overdeck's ten largest holdings make up 9.4% of its $15.7B portfolio in Q3 2013.
- John Overdeck opened 482 new positions and closed 621 in Q3 2013.
- John Overdeck's portfolio value rose 9.6% quarter-over-quarter to $15.7B.
Based on Two Sigma Investments's 13F filing for Q3 2013, filed 14 Nov 2013.